Orly Mishan
Fortune : - $ au 31/08/2026
Fortune : - $ au 31/08/2026
Ms. Orly Mishan is a Chairman at Adagio Medical Holdings, Inc. She is on the Board of Directors at Kestra Medical Technologies, Inc. Ms. Mishan was previously employed as a Managing Director by Perceptive Advisors (Private Equity), a Chief Business Officer by Cerevel Therapeutics Holdings, Inc., a Principal by Bain Capital Life Sciences LP, and a Vice President by Biogen, Inc. She also served on the board at Boston Scientific.
She received her undergraduate degree from Columbia College (California).
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
-.--% | 16/06/2026 | 0 ( -.--% ) | - $ | 31/08/2026 |
| Sociétés | Poste | Début |
|---|---|---|
Kestra Medical Technologies, Inc.
Kestra Medical Technologies, Inc. Medical SpecialtiesHealth Technology Provides medical technologies to protect and support at-risk patients | Directeur/Membre du Conseil | 01/11/2017 |
| Sociétés | Poste | Fin |
|---|---|---|
| CEREVEL THERAPEUTICS HOLDINGS, INC. | Corporate Officer/Principal | 01/03/2021 |
| BIOGEN INC. | Corporate Officer/Principal | 02/01/2017 |
Boston Scientific
Boston Scientific Medical SpecialtiesHealth Technology Manufacturer medical devices | Directeur/Membre du Conseil | 01/09/2014 |
Perceptive Advisors (Private Equity)
Perceptive Advisors (Private Equity) Investment ManagersFinance Perceptive Advisors invests in public and private middle market companies located across the globe. The firm focuses across a broad range of sectors and industries. It provides financing in the form of equity and debt for seed, early, later stage and growth transactions with an investment size of USD 10 – 300 million. The firm acts as lead and co-lead investor. It also takes a seat on a board of directors. | Private Equity Investor | - |
Bain Capital Life Sciences LP
Bain Capital Life Sciences LP Investment ManagersFinance Bain Capital Life Sciences invests in public and private companies located across the globe. The firm focuses on biopharmaceutical, specialty pharmaceuticals, medical device, diagnostic and life science technology sectors. It provides financing for buyout and growth stage capital requirements with an investment size of USD 25 - 100 million. | Private Equity Investor | - |
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
| Entreprise privées | 7 |
|---|---|
Biogen, Inc.
Biogen, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets therapies for neurological and neurodegenerative diseases | Health Technology |
Columbia College (California)
Columbia College (California) Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Boston Scientific
Boston Scientific Medical SpecialtiesHealth Technology Manufacturer medical devices | Health Technology |
Bain Capital Life Sciences LP
Bain Capital Life Sciences LP Investment ManagersFinance Bain Capital Life Sciences invests in public and private companies located across the globe. The firm focuses on biopharmaceutical, specialty pharmaceuticals, medical device, diagnostic and life science technology sectors. It provides financing for buyout and growth stage capital requirements with an investment size of USD 25 - 100 million. | Finance |
Kestra Medical Technologies, Inc.
Kestra Medical Technologies, Inc. Medical SpecialtiesHealth Technology Provides medical technologies to protect and support at-risk patients | Health Technology |
Perceptive Advisors (Private Equity)
Perceptive Advisors (Private Equity) Investment ManagersFinance Perceptive Advisors invests in public and private middle market companies located across the globe. The firm focuses across a broad range of sectors and industries. It provides financing in the form of equity and debt for seed, early, later stage and growth transactions with an investment size of USD 10 – 300 million. The firm acts as lead and co-lead investor. It also takes a seat on a board of directors. | Finance |
Cerevel Therapeutics Holdings, Inc.
Cerevel Therapeutics Holdings, Inc. BiotechnologyHealth Technology Operates as a clinical stage biotechnology company that develops novel therapies for neurological and psychiatric disorders | Health Technology |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national